Ticker > IPO > Upcoming IPO > Veeda Clinical Research Ltd.

Veeda Clinical Research Ltd. IPO

RHP
View
DRHP
View
Open Date

Not Issued

Close Date

Not Issued

IPO Details

Check out the issue details for Veeda Clinical Research Ltd. IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

831.6 Cr.

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

News

 IPO news not found.

Company Financials

You can get the following financial statements of Veeda Clinical Research Ltd. as of now.

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Subscription Details

The approx valuation of Veeda Clinical Research IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Not issued
Existing Shares (Qty) 4.62 Cr
Fresh Issue 331.6 Cr
EPS (FY21) Rs 15.39

 

Veeda Clinical Research IPO issue size is 831.6 Cr:

Issue Amount
Fresh Issue 331.6 Cr
Offer For Sale 500 Cr

 

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%
Employee  Not Disclosed

Allotment Details

The dates for the IPO is not issued yet. Check this space later on.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 130.85 182.45 218.44 151.27 195.81
Total Expenditure 107.95 122.18 136.14 131.89 129.1
Operating Profit 22.9 60.27 82.31 19.39 66.72
Other Income 5.57 0.78 5.34 2.41 38.57
Interest 2.64 2.7 2.38 5.09 4.81
Depreciation 11.26 10.58 9.44 15.8 14.95
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.58 47.77 75.82 0.9 85.53
Provision for Tax 4.63 16.86 23.2 0.94 22.25
Net Profit 9.96 30.91 52.62 -0.04 63.29
Adjusted EPS (Rs.) 0.3 0.94 0.76 0 1.76

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 17.59 17.59 35.82 35.82 35.83
Total Reserves 36.5 67.41 53.69 52.18 133.93
Borrowings 12.99 10 0 0 0
Other N/C liabilities -1.12 -1.49 -0.17 32.47 34.8
Current liabilities 35.62 32.18 39.82 55.57 74.75
Total Liabilities 101.56 125.68 129.17 176.04 279.31
Assets
Net Block 45.43 43.92 37.75 77.66 74.36
Capital WIP 0.31 0.39 7.41 0 0.46
Intangible WIP 0 0.2 0.33 0.51 0.67
Investments 0.14 0.14 0 0 37.02
Loans & Advances 22.86 25.21 10.43 17.58 41.38
Other N/C Assets 0.19 0.43 0.4 4.85 4.89
Current Assets 32.63 55.39 72.84 75.44 120.52
Total Assets 101.56 125.68 129.17 176.04 279.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 14.58 47.77 75.82 0.9 85.53
Adjustment 13.03 12.94 8.24 19.66 18.34
Changes in Assets & Liabilities -13.67 -18.57 14.19 -2.29 -4.22
Tax Paid -6.99 -17.26 -23.03 -9.14 -23.03
Operating Cash Flow 6.96 24.89 75.23 9.13 76.63
Investing Cash Flow -8.37 -11.96 -8.63 -8.93 -93.15
Financing Cash Flow 1.48 -6.46 -55.57 -3.45 17.07
Net Cash Flow 0.06 6.46 11.02 -3.25 0.55
X